http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060053013-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae10212794160b34478f0d05b6ab6fd7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015 |
| filingDate | 1998-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9297061457b7e56937695489529c19c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028699d20006bf51b609b15d01db457c |
| publicationDate | 2006-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20060053013-A |
| titleOfInvention | Pharmaceutical composition containing substituted alkano hydroxamic acid as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition containing substituted alkano hydroxamic acid as an active ingredient, and by using the substituted alkano hydroxamic acid derivative of the present invention having an excellent effect of reducing TNFα concentration, Not only can provide pharmaceutical compositions for the treatment or prevention of eggplant inflammatory, infectious, immune or malignant diseases, but also can be used for the veterinary treatment of mammals other than humans in need of suppression or prevention of TNFα production. There is. |
| priorityDate | 2006-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.